Börsipäev 12. juuni
Kommentaari jätmiseks loo konto või logi sisse
-
Reedene päev tõi Ühendriikides üsna dramaatilise ümberpositsioneerimise, mis liigutas S&P 500 indeksit kokkuvõttes vaid -0,1%, kuid kujundas sektorite lõikes oluliselt suuremaid erinevusi. Pikalt turgu vedanud tehnoloogiasektoris võeti kasumit (-2,7%), mille üheks põhjuseks võis olla ülekuumenemisest hoiatanud Goldman Sachsi analüüs, suunates kapitali ümber viimastel kuudel kehvemini esinenud energia- (+2,5%) ja finantssektori aktsiatesse (+1,9%). Nädala lõikes kaotas S&P 500 -0,3%, samal ajal aga jättis reedene tagasilöök Nasdaqi -1,6% punasesse.
Euroopa aktsiad kosusid reedel Suurbritannia eksportijate eestvedamisel 0,3%, vähendades nädala lõikes Stoxx 600 kaotust -0,6%ni. Suurema ülespoole liikumise tegid reedel Fingerprint Cards +7.1%, Fresnillo +3.6%, LANXESS +3.6%, Unione di Banche Italiane +3.5%, Antofagasta +3.5%. Enim langesid Berkeley Group Holdings -3.6%, Uniper -3.3%, Taylor Wimpey -3.3%, AA -3.1%, Travis Perkins -3.0%.
Pühapäeval otsustasid Prantsusmaa valijad koonduda oma presidendi Emmanuel Macroni selja taha, andes tema parteile parlamendi valimiste esimeses ringis ülekaaluka enamuse. Aastakümneid vaheldumisi võimul olnud sotsialiste ning konservatiive kõrval tõrjudes kogus Macroni veidi üle aasta tegutsenud erakond La République En Marche koos liitlase MoDem’iga 32,3% häältest, mis võib anda 577kohalises parlamendis kuni 455 kohta. Valimiste teine ring leiab aset käesoleval pühapäeval.
Käesolev nädal toob mitmeid tähtsaid sündmusi, millest kerkivad esile USA, Inglise ja Jaapani keskpanga istungid ja euroala rahandusministrite kohtumine, kus arutatakse Kreekale järgmise laenueraldise andmist ja potentsiaalselt ka võlakoormat leevendavaid lahendusi. Statistika raskuskese langeb kolmapäevale, mil selgub USA maikuu jaemüük, Hiina maikuu tööstustoodang, jaemüük ja investeeringud. Tänane börsipäev toob vaid Itaalia aprilli tööstustoodangu ning USA valitsuse mai eelarve maikuu ülevaate.
11.00 Itaalia tööstustoodang (aprill)
21.00 USA valitsuse eelarve (mai) -
Itaalia tööstustoodang alanes aprillis MoM -0,4%, jäädes alla analüütikute 0,2% prognoosile. Mullusega võrreldes aeglustus kasv 2,9% pealt 1,0% (oodati 2,5%).
-
UPGRADES:
* CACI (CACI) raised to outperform at Cowen, PT $145
* Coherent (COHR) raised to buy at Longbow, PT $325
* Digital Realty (DLR) raised to outperform at Cowen, PT $128
* Ultra Petroleum (UPL) raised to buy at Stifel, PT $16
DOWNGRADES:
* American Tower (AMT) cut to outperform at Raymond James, PT$147
* Apple (AAPL) cut to neutral at Mizuho, PT $150
* Crown Castle (CCI) cut to market perform at Raymond James
* DuPont Fabros (DFT) cut to neutral at Baird, PT $63
* Mogo Finance Technology (MOGO CN) cut to hold at Canaccord, PTC$3.75
* Pandora Media (P) cut to market perform at Oppenheimer
* Ramco-Gershenson (RPT) cut to market perform at Raymond James
* SBA Comms (SBAC) cut to outperform at Raymond James, PT $153
INITIATIONS:
* Argenx (ARGX BB) new outperform at Cowen
* Cigna (CI) new outperform at Credit Suisse, PT $185
* G1 Therapeutics (GTHX) new buy at Needham, PT $34
* G1 Therapeutics (GTHX) new outperform at Cowen
* G1 Therapeutics (GTHX) new outperform at Wedbush, PT $31
* G1 Therapeutics (GTHX) new overweight at JPMorgan, PT $23
* Henry Schein (HSIC) new neutral at Piper Jaffray, PT $200
* United Technologies (UTX) new hold at HSBC, PT $125 -
Gapping up
In reaction to strong earnings/guidance: N/A.
M&A news:
SIEN +3% (to acquire Miramar Labs for an aggregate transaction value of $20 mln in upfront cash plus contractual rights for potential contingent payments)
Other news:
TROV +37% (enters into an agreement with AstraZeneca (AZN) to provide Trovera urine ctDNA biomarker test and services)
ABIL +16.6% (continued volatility in pre-mkt)
FCSC +16% (FDA has granted Rare Pediatric Disease Designation to FCX-013)
QIWI +12.7% (still checking)
APOP +9.1% (receives a formal notice of allowance for patent application No. 14/383,288 covering a key composition of matter and method of use)
XBIT +7.5% (modestly rebounding following Friday's declines)
GNMK +7.5% (receives 510(k) market clearance from the FDA for both its ePlex instrument and Respiratory Pathogen Panel)
EIGR +5.8% (announces positive data from the Phase 2 multiple-ascending dose study evaluating subcutaneous exendin 9-39)
MZOR +4.4% (modestly rebounding from last week's decline)
GTXI +4.2% (presents prelim data from its Phase 2 clinical trial of enobosarm)
GE +3.6% (names John Flannery Chairman and CEO; Jeff Immelt to retire at the end of the year)
CNIT +2.8% (signs $1 mln cloud-based ad terminal contract for Anhui Province)
HLT +2.4% (will replace Yahoo! in the S&P 500)
TSRO +2.3% (provides update regarding the status of a clinical trial of niraparib sponsored by Janssen Biotech (JNJ); temporary enrollment hold is not due to any safety concerns)
NVO +1.7% (presents study suggesting switching to Tresiba provides significant reductions in blood glucose and lower rates of hypoglycaemia)
Analyst comments:
VOD +1.3% (upgraded to Buy from Hold at Argus)
Gapping down
In reaction to disappointing earnings/guidance: N/A.
Select Tech related names showing additional weakness in pre-mkt:
AMD -4.4%, NVDA -3%, MOMO -2.5%, ATVI -2.1%, AMAT -1.9%, NFLX -1.8%, TSLA -1.8%, MU -1.8%, WDC -1.8%, FEYE -1.6%, MSFT -1.6%, FB -1.3%, AMZN -1.1%
Other news:
CHRS -32.2% (issued a complete response letter for its biologics license application for CHS-1701)
VALE -1.2% (successfully completed a $ 2 billion syndicated revolving credit facility, which will be available for five years)
Analyst comments:
P -3.6% (downgraded to Perform from Outperform at Oppenheimer)
ADBE -2.9% (downgraded to Sell from Hold at Pivotal Research Group)
AAPL -2% (downgraded to Neutral from Buy at Mizuho)
SNN -1.1% (downgraded to Sell from Hold at Investec)
HSBC -0.8% (downgraded to Sell from Hold at Investec)
Briefing.com
